Adenocarcinoma of Prostate Clinical Trial
Official title:
Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy
Transrectal ultrasound guided prostate biopsy (TRUS-Bx) is the gold standard method for
prostat cancer diagnosis. Cancer detection rate is an important issue in TRUS-Bx. Effective
biopsy protocol is necessary to enhance cancer detection rate during the procedure. Patient
tolerance may improve the protocol effectiveness and quality.
Adequate patient tolerance with optimal local anesthesia may enhance cancer detection rate in
TRUS-Bx.
In transrectal ultrasound guided prostate biopsy ultrasound's probe manipulation is necessary
for effective biopsy. Patient discomfort and pain frequently occurs with manipulation of
probe during transrectal ultrasound guided prostate biopsy and this situation may qualify of
the achievement of this procedure.
In this study, we aimed to describe the impact of different two local anesthesia types on
cancer detection rate in transrectal ultrasound guided prostate biopsy.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02258087 -
HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04687969 -
Multimodal Machine Learning Characterization of Solid Tumors
|
||
| Recruiting |
NCT02672449 -
Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate Cancer
|
N/A | |
| Completed |
NCT02342626 -
Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer
|
N/A | |
| Active, not recruiting |
NCT01913717 -
Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion
|
N/A | |
| Completed |
NCT00140478 -
Mifepristone (RU-486) in Androgen Independent Prostate Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01952223 -
A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse
|
Phase 3 | |
| Completed |
NCT03518853 -
Short Course Radiotherapy for Localized Prostate Cancer
|
N/A | |
| Active, not recruiting |
NCT01994239 -
Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy
|
Phase 2 | |
| Terminated |
NCT02024685 -
Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial
|
N/A |